Top Stem Cell Researcher Set to Introduce Studies on Stem Cell Treatments at World Economic Forum in Davos

Jan. 16, 2015ZURICH, SwitzerlandWorld-renowned stem cell researcher and founder of Blue Horizon International (BHI) and Blue Horizon Stem Cells (BHSC), Brian Mehling, MD, will be in attendance to discuss his studies during The World Economic Forum Annual Meeting on Jan. 21-24 in Davos-Klosters, Switzerland.

More than 40 heads of state and government, as well as 2,500 other leaders from business and society will convene at the 45th annual meeting.

“Stem cell treatments are without a doubt the future of medicine and we believe their role in treatments will become the preferred substitutes for many surgical, pharmacological, and rehabilitative medical services,” Dr. Mehling stated.  “It is very important that people making decisions on what direction the world will take in regards to research and medical treatments are educated about not only the possibilities in stem cell research, but also about all the treatments that are already available for many patients with different chronic conditions, disorders, and acute diseases. ”

“The World Economic Forum serves the international community as a platform for public-private cooperation,” said Klaus Schwab, Founder and Executive Chairman of the World Economic Forum.

Participants include more than 1,500 business leaders from the Forum’s 1,000 Member companies, 300 public figures as well as recognized leaders from other Forum communities, including Social Entrepreneurs, Global Shapers, Young Global Leaders and Technology Pioneers. Representatives from international organizations and civil society, as well as religious leaders, cultural leaders, academia and the media will also participate.The full programme consists of over 280 sessions out of which over 100 sessions will be live webcast.